Crescent Biopharma, Inc. (CBIO)
20.73
+1.28
(+6.58%)
USD |
NASDAQ |
Apr 17, 12:12
Crescent Biopharma Total Assets (Quarterly) : 240.29M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.564B |
| Agenus, Inc. | 226.80M |
| Alnylam Pharmaceuticals, Inc. | 5.026B |
| Savara, Inc. | 253.44M |
| Arrowhead Pharmaceuticals, Inc. | 1.604B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 37.28M |
| Shareholders Equity (Quarterly) | 203.01M |
| Debt to Equity Ratio | 0.0081 |
| Current Ratio | 6.561 |
| Net Debt Paydown Yield | -0.08% |